Signe Friesland

Artiklar

Article: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2025;47(2):586-598
"High-risk" tumors of the lip treated with external beam radiotherapy and high-dose-rate brachytherapy: Long-term outcome
Mercke C; Friesland S; Berglund A; Johansson GW; Margolin G; Gubanski M; Bjorgvinsson E; Nilsson J
Article: RADIOTHERAPY AND ONCOLOGY. 2025;202:110612
Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer
de Leeuw ALMP; Giralt J; Tao Y; Benavente S; Nguyen T-VF; Hoebers FJP; Hoeben A; Terhaard CHJ; Lee LW; Friesland S; Steenbakkers RJHM; Tans L; van Kranen SR; van de Kamer JB; Bartelink H; Rasch CRN; Sonke J-J; Hamming-Vrieze O
Article: RADIOTHERAPY AND ONCOLOGY. 2024;196:110281
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)
de Leeuw ALMP; Giralt J; Tao Y; Benavente S; Nguyen T-VF; Hoebers FJP; Hoeben A; Terhaard CHJ; Lee LW; Friesland S; Steenbakkers RJHM; Tans L; Heukelom J; Kayembe MT; van Kranen SR; Bartelink H; Rasch CRN; Sonke J-J; Hamming-Vrieze O
Article: CANCERS. 2023;15(9):2580
Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects
Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Friesland S
Article: CANCERS. 2023;15(9):2543
Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II Trial
Mercke C; Wickart-Johansson G; Sjodin H; Farrajota Neves da Silva P; von Dobeln GA; Margolin G; Jonmarker Jaraj S; Carstens H; Berglund A; Lax I; Hellstrom M; Hammarstedt-Nordenvall L; Friesland S
Article: RADIATION ONCOLOGY. 2023;18(1):65
Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Friesland S
Article: CANCERS. 2023;15(5):1499
Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort
Zupancic M; Nasman A; Berglund A; Dalianis T; Friesland S
Article: ACTA OTO-LARYNGOLOGICA. 2023;143(1):77-84
Brachytherapy and osteoradionecrosis in patients with base of tongue cancer
Danielsson D; Hagel E; Dybeck-Udd S; Sjostrom M; Kjeller G; Bengtsson M; Abtahi J; von Beckerath M; Thor A; Halle M; Friesland S; Mercke C; Westermark A; Hogmo A; Munck-Wikland E
Article: VIRUSES-BASEL. 2022;14(5):1040
Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features
Zupancic M; Holzhauser S; Cheng L; Ramqvist T; Du J; Friesland S; Nasman A; Dalianis T
Article: ACTA ONCOLOGICA. 2021;60(11):1459-1465
Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
Ullgren H; Camuto A; Rosas S; Pahnke S; Ginman B; Enblad G; Glimelius I; Fransson P; Friesland S; Liu L
Article: CANCERS. 2021;13(13):3173
Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects
Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Bornedal S; Wennberg B; Dalqvist E; Friesland S
Article: CANCERS. 2021;13(11):2553
Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
Wendt M; Hammarstedt-Nordenvall L; Zupancic M; Friesland S; Landin D; Munck-Wikland E; Dalianis T; Nasman A; Marklund L
Article: EUROPEAN JOURNAL OF CANCER. 2021;145:245-254
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
Skribek M; Rounis K; Afshar S; Grundberg O; Friesland S; Tsakonas G; Ekman S; De Petris L
Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(1):38-47
ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
Gebre-Medhin M; Brun E; Engstrom P; Haugen Cange H; Hammarstedt-Nordenvall L; Reizenstein J; Nyman J; Abel E; Friesland S; Sjodin H; Carlsson H; Soderkvist K; Thomasson M; Zackrisson B; Nilsson P
Article: CANCERS. 2020;12(11):E3110-3110
Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin Vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)
Tsakonas G; Specht L; Kristensen CA; Moreno MHC; Haugen Cange H; Soderstrom K; Friesland S
Article: CANCERS. 2020;12(7):E1804-1804
ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases
Tsakonas G; Kamali C; De Petris L; Friesland S; Lewensohn R; Ekman S
Article: RADIATION ONCOLOGY. 2020;15(1):147
Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selection
Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Bornedal S; Wennberg B; Friesland S
Article: EUROPEAN JOURNAL OF CANCER. 2020;132:24-34
An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer
Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
Article: FRONTIERS IN ONCOLOGY. 2020;10:1647
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study
Onjukka E; Mercke C; Bjorgvinsson E; Embring A; Berglund A; Alexandersson von Dobeln G; Friesland S; Gagliardi G; Lenneby Helleday C; Sjodin H; Lax I
Article: BRITISH JOURNAL OF SURGERY. 2019;106(11):1452-1463
Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)
Sunde B; Klevebro F; Johar A; Johnsen G; Jacobsen A-B; Glenjen NI; Friesland S; Lindblad M; Ajengui A; Lundell L; Lagergren P; Nilsson M
Article: JAMA ONCOLOGY. 2019;5(8):1170-1180
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
Burtness B; Haddad R; Dinis J; Trigo J; Yokota T; Viana LDS; Romanov I; Vermorken J; Bourhis J; Tahara M; Martins Segalla JG; Psyrri A; Vasilevskaya I; Nangia CS; Chaves-Conde M; Kiyota N; Homma A; Holeckova P; Del Campo JM; Asarawala N; Nicolau UR; Rauch D; Even C; Wang B; Gibson N; Ehrnrooth E; Harrington K; Cohen EEW; Eduardo Giglio R; Raul Blajman C; Mario Freue J; Graciela Pilnik N; Salvador Palazzo F; McGrath M; Fureder T; Kornek G; Pichler A; Bauernhofer T; Tinchon C; Greil R; Burian M; Kienzer H; Specenier P; Sautois B; Debruyne P; Graas M-P; Maes A; Lonchay C; Daisne J-F; Fontaine C; Castro Junior G; de Oliveira F; Pereira RP; Martins De Marchi PR; Viana LDS; Martins Segalla JG; Nicolau UR; Lazaretti NS; Kulkarni S; Alam Y; Ho C; Shenouda G; Soulieres D; Sultanem K; Singh S; Gonzalez Mella P; Solis Campos JA; Holeckova P; Prausova J; Obermannova R; Friborg J; Specht L; Elsaid AA; Minn H; Martin L; Rolland F; Ceruse P; Calais G; Even C; Guigay J; Ferte C; Peyrade F; Duffaud F; Champeaux-Orange E; Coutte A; Clatot F; Fournel P; Le Moal LB; Dietz A; Gruenwald V; Gauler T; Guntinas-Lichius O; Hildebrandt G; Kuhnt T; Schmidt H-J; Henke M; Rueckert A; Brugger W; Rotter N; Mahlberg R; Karavasilis V; Fountzilas G; Psyrri D; Lang I; Boer A; Kocsis J; Pajkos G; Tamas L; Anand AL; Sharma A; Sharma; Voona M; Pandy AS; Kumar K; Nathan RKP; Srinivasan V; Zade B; Jain M; Srinivasa BJ; Naik R; Mohanty BK; Asarawala N; Charas T; Billan S; Popovtzer A; Licitra L; Ferrari D; Fao P; Merlano M; Rocca MC; Homma A; Fujii H; Tahara M; Minami S; Fujii M; Yokota T; Kadowaki S; Muro K; Kiyota N; Okami K; Yagi T; Yoshino K; Matsumoto K; Takahashi S; Matsuura K; Alvarez Avitia MA; Gonzalez Riestra HJ; van Meerten E; Buter J; Gelderblom AJ; Kawecki A; Golusinski W; Dinis J; Dinis R; Ribeiro L; Silva R; Mansinho H; Selezneva I; Biakhov M; Galiulin R; Izmailov A; Romanov I; Vladimirov V; Vinogradov V; Mufazalov F; Vasilevskaya I; Baste N; Ma del Campo J; Mesia Nin R; Lopez Pousa A; Jose Grau de Castro J; Reig O; Vera R; Trigo J; Iglesias L; Martinez Trufero J; Vazquez S; Rubio B; Enrique Ales J; Villar E; Rubio J; Escobar Y; Soria A; Chaves M; Johansson GW; Friesland S; Tell R; Nyman J; Rothschild S; Zippelius A; Rauch D; Usluoglu N; Gogunska I; Zabolotniy D; Vinnyk Y; Burian O; Harrington K; Sykes A; Peel D; Lester J; Robinson M; Srinivasan D; Fragkandrea-Nixon I; Junor E; Gollins S; Evans M; Newbold K; Hwang D; Schipani S; Rizwanullah M; Atiq O; Arnaoutakis K; Bauman J; Burtness B; Mehra R; Kang H; Chung C; Davis T; Haddad R; Jimeno A; Keresztes R; Nangia C; Ignatius S-H; Su YB; Overton LC; Garrison MA; Jeong W; Wehbe A; Argiris A; Chiang A; Morgensztern D; Haigentz MJ; Martincic D; Porosnicu M
Article: DISEASES OF THE ESOPHAGUS. 2019;32(2):doy078
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
von Dobeln GA; Klevebro F; Jacobsen A-B; Johannessen H-O; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M
Article: DISEASES OF THE ESOPHAGUS. 2019;32(2):doy069
Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
Sunde B; Johnsen G; Jacobsen A-B; Glenjen NI; Friesland S; Lindblad M; Rouvelas I; Wang N; Lundell L; Lagergren P; Nilsson M
Article: LANCET. 2019;393(10167):156-167
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW; Soulières D; Le Tourneau C; Dinis J; Licitra L; Ahn M-J; Soria A; Machiels J-P; Mach N; Mehra R; Burtness B; Zhang P; Cheng J; Swaby RF; Harrington KJ; KEYNOTE-040 investigators
Article: LUNG CANCER. 2018;122:180-186
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial
Hallqvist A; Bergstrom S; Bjorkestrand H; Svard A-M; Ekman S; Lundin E; Holmberg E; Johansson M; Friesland S; Nyman J
Article: ACTA ONCOLOGICA. 2018;57(2):231-238
Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer
Tsakonas G; Hellman F; Gubanski M; Friesland S; Tendler S; Lewensohn R; Ekman S; de Petris L
Article: RADIOTHERAPY AND ONCOLOGY. 2016;121(1):1-8
SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC
Nyman J; Hallqvist A; Lund J-A; Brustugun O-T; Bergman B; Bergstrom P; Friesland S; Lewensohn R; Holmberg E; Lax I
Article: DISEASES OF THE ESOPHAGUS. 2016;29(5):442-447
Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction
Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
Article: LANGENBECKS ARCHIVES OF SURGERY. 2016;401(3):323-331
Neoadjuvant chemoradiotherapy may increase the risk of severe anastomotic complications after esophagectomy with cervical anastomosis
Klevebro F; Friesland S; Hedman M; Tsai JA; Lindblad M; Rouvelas I; Lundell L; Nilsson M
Article: ANNALS OF ONCOLOGY. 2016;27(4):660-667
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
Klevebro F; von Dobeln GA; Wang N; Johnsen G; Jacobsen A-B; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M
Article: RADIOTHERAPY AND ONCOLOGY. 2016;118(2):335-341
Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up
Nyqvist J; Fransson P; Laurell G; Hammerlid E; Kjellen E; Franzen L; Soderstrom K; Wickart-Johansson G; Friesland S; Sjodin H; Brun E; Ask A; Nilsson P; Ekberg L; Bjork-Eriksson T; Nyman J; Loden B; Lewin F; Reizenstein J; Lundin E; Zackrisson B
Article: RADIOTHERAPY AND ONCOLOGY. 2015;117(1):99-105
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial
Zackrisson B; Kjellen E; Soderstrom K; Brun E; Nyman J; Friesland S; Reizenstein J; Sjodin H; Ekberg L; Loden B; Franzen L; Ask A; Wickart-Johansson G; Lewin F; Bjork-Eriksson T; Lundin E; Dalianis T; Wennerberg J; Johansson K-A; Nilsson P
Article: ANTICANCER RESEARCH. 2015;35(10):5491-5497
Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy
Holgersson G; Bergstrtom S; Liv P; Nilsson J; Edlund P; Blomberg C; Nyman J; Friesland S; Ekman S; Asklund T; Henriksson R; Bergqvist M
Article: ACTA ONCOLOGICA. 2015;54(8):1096-1104
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience
Lindberg K; Nyman J; Kallskog VR; Hoyer M; Lund JA; Lax I; Wersall P; Karlsson K; Friesland S; Lewensohn R
Article: EJSO. 2015;41(7):920-926
Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
Klevebro F; Johnsen G; Johnson E; Viste A; Myrnas T; Szabo E; Jacobsen A-B; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
Article: MEDICAL ONCOLOGY. 2013;30(1):320
The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer
Holgersson G; Bergqvist M; Nyman J; Hoye E; Helsing M; Friesland S; Holgersson M; Ekberg L; Morth C; Ekman S; Blystad T; Ewers S-B; Loden B; Henriksson R; Bergstrom S
Article: MEDICAL ONCOLOGY. 2012;29(5):3176-3182
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
Holgersson G; Sandelin M; Hoye E; Bergstrom S; Henriksson R; Ekman S; Nyman J; Helsing M; Friesland S; Holgersson M; Lundstrom KL; Janson C; Birath E; Morth C; Blystad T; Ewers S-B; Loden B; Bergqvist M
Article: MEDICAL ONCOLOGY. 2012;29(5):3431-3439
A retrospective study of SBRT of metastases in patients with primary sarcoma
Stragliotto CL; Karlsson K; Lax I; Rutkowska E; Bergh J; Strander H; Blomgren H; Friesland S
Article: DISEASES OF THE ESOPHAGUS. 2012;25(5):410-415
Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer - results of a prospective safety study
Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
Article: ACTA ONCOLOGICA. 2012;51(6):759-767
Swedish Lung Cancer Radiation Study Group: Predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer
Holgersson G; Hoye E; Bergqvist M; Ekman S; Nyman J; Helsing M; Friesland S; Holgersson M; Ekberg L; Blystad T; Ewers S-B; Morth C; Loden B; Henriksson R; Bergstrom S
Article: ANTICANCER RESEARCH. 2012;32(4):1339-1346
The Value of Induction Chemotherapy for Survival in Patients with Non-small Cell Lung Cancer Treated with Radiotherapy
Holgersson G; Sandelin M; Hoye E; Bergstrom S; Henriksson R; Ekman S; Nyman J; Helsing M; Friesland S; Brodin O; Holgersson M; Lundstrom KL; Janson C; Ekberg L; Morth C; Blystad T; Ewers S-B; Loden B; Bergqvist M
Article: EUROPEAN JOURNAL OF CANCER. 2011;47(16):2415-2421
Swedish Lung Cancer Radiation Study Group: Predictive value of histology for radiotherapy response in patients with non-small cell lung cancer
Holgersson G; Bergstrom S; Bergqvist M; Nyman J; Hoye E; Helsing M; Friesland S; Holgersson M; Birath E; Ekrnan S; Blystad T; Ewers S-B; Morth C; Loden B; Henriksson R
Article: RADIOTHERAPY AND ONCOLOGY. 2011;100(1):41-48
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma The ARTSCAN study
Zackrisson B; Nilsson P; Kjellen E; Johansson K-A; Modig H; Brun E; Nyman J; Friesland S; Reizenstein J; Sjodin H; Ekberg L; Loden B; Mercke C; Fernberg J-O; Franzen L; Ask A; Persson E; Wickart-Johansson G; Lewin F; Wittgren L; Bjor O; Bjork-Eriksson T
Article: LAKARTIDNINGEN. 2011;108(20):1092-1093
[Paradigmatic shift in oncology: individualized melanoma treatment].
Hansson J; Djureen-Mårtenson E; Edvinsson F; Falkenius J; Friesland S; Masucci G; Månsson-Brahme E; Ragnarsson-Olding B; Sjödin H; Wolodarski M; Frohm-Nilsson M; Lapins J
Article: RADIOTHERAPY AND ONCOLOGY. 2010;97(1):54-59
Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy
Alevronta E; Ahlberg A; Mavroidis P; al-Abany M; Friesland S; Tilikidis A; Laurell G; Lind BK
Article: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2010;32(4):452-461
ESOPHAGEAL STRICTURE AFTER RADIOTHERAPY IN PATIENTS WITH HEAD AND NECK CANCER: EXPERIENCE OF A SINGLE INSTITUTION OVER 2 TREATMENT PERIODS
Ahlberg A; al-Abany M; Alevronta E; Friesland S; Hellborg H; Mavroidis P; Lind BK; Laurell G
Article: JOURNAL OF CLINICAL ONCOLOGY. 2009;27(20):3290-3296
Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy
Baumann P; Nyman J; Hoyer M; Wennberg B; Gagliardi G; Lax I; Drugge N; Ekberg L; Friesland S; Johansson K-A; Lund J-A; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
Article: LUNG CANCER. 2009;65(1):62-67
How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group
Nyman J; Friesland S; Hallqvist A; Seke M; Bergstrom S; Thaning L; Loden B; Sederholm C; Wagenius G
Article: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2009;135(2):203-209
In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR
Laytragoon-Lewin N; Ustun H; Castro J; Friesland S; Ghaderi M; Lundgren J; Turesson I; Lewin F
Article: ANTICANCER RESEARCH. 2008;28(5B):2851-2857
Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Tell R; Sederholm C; Klintenberg C; Franksson L; Branden E; Hillerdal G; Lonn U; Linden C-J; Ewers S-B; Lamberg K; Mrazek E; Loden B; Sjogren A; Linne T; Friesland S; Sirzen F
Article: RADIOTHERAPY AND ONCOLOGY. 2008;88(3):359-367
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
Baumann P; Nyman J; Hoyer M; Gagliardi G; Lax I; Wennberg B; Drugge N; Ekberg L; Friesland S; Johansson K-A; Lund J-A; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
Article: RADIOTHERAPY AND ONCOLOGY. 2008;87(2):290-299
The quality assurance process for the ARTSCAN head and neck study -: A practical interactive approach for QA in 3DCRT and IMRT
Johansson K-A; Nilsson P; Zackrisson B; Ohlson B; Kjellen E; Mercke C; Alvarez-Fonseca M; Billstrom A; Bjork-Eriksson T; Bjor O; Ekberg L; Friesland S; Karlsson M; Lagerlund M; Lundkvist L; Lofroth P-O; Lofvander-Thapper K; Nilsson A; Nyman J; Persson E; Reizenstein J; Rosenbrand H-O; Wikund F; Wittgren L
Article: ACTA OTO-LARYNGOLOGICA. 2008;128(12):1354-1360
Clinical outcome following radiotherapy and planned neck dissection in N plus head and neck cancer patients
Ahlberg A; Lagerlund M; Lewin F; Friesland S; Lundgren J
Article: MEDICAL ONCOLOGY. 2007;24(4):407-412
Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer
Albertsson M; Johansson B; Friesland S; Kadar L; Letocha H; Frykholm G; Wagenius G
Article: MEDICAL ONCOLOGY. 2007;24(1):95-102
Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice
Bremberg ER; Brandberg Y; Hising C; Friesland S; Eksborg S
Article: ADVANCES IN THERAPY. 2005;22(3):208-224
Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: Comparative analysis of drug utilization, costs, and hematologic response
Persson U; Borg S; Jansson S; Ekman T; Franksson L; Friesland S; Larsson AM
Article: MEDICAL ONCOLOGY. 2005;22(4):375-381
Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer
De Petris L; Lax I; Sirzén F; Friesland S
Article: ANTICANCER RESEARCH. 2003;23(3C):2821-2828
Human papillomavirus and DNA ploidy in tonsillar cancer - Correlation to prognosis
Mellin H; Friesland S; Auer G; Dalianis T; Munck-Wikland E
Article: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2003;25(4):313-321
Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy
Friesland S; Kanter-Lewensohn L; Tell R; Munck-Wikland E; Lewensohn R; Nilsson A
Article: MEDICAL ONCOLOGY. 2001;18(3):231-235
GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy
Fernberg JO; Brosjö O; Friesland S; Masucci G
Article: ACTA ONCOLOGICA. 2001;40(1):24-28
Outcome of ipsilateral treatment for patients with metastases to neck nodes of unknown origin
Friesland S; Lind MG; Lundgren J; Munck-Wikland E; Fernberg JO
Article: ANTICANCER RESEARCH. 2001;21(1B):529-534
Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma - Relation to radiotherapy response and survival
Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R
Article: INTERNATIONAL JOURNAL OF CANCER. 2000;89(3):300-304
Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival
Mellin H; Friesland S; Lewensohn R; Dalianis T; Munck-Wikland E
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 1999;45(5):1259-1266
Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: A retrospective analysis of the radiumhemmet data, 1980-1995
Friesland S; Fernberg JO; Lundell G; Munck-Wikland E; Strander H; Lewensohn R
Visa fler

Alla övriga publikationer

Review: ANTICANCER RESEARCH. 2024;44(4):1325-1334
Adenoid Cystic Carcinoma, Clinical Presentation, Current Treatment and Approaches Towards Novel Therapies
Zupancic M; Naesman A; Friesland S; Dalianis T
Other: CASE REPORTS IN ONCOLOGY. 2023;16(1):525-531
Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report
Zupancic M; Farrajota Neves da Silva P; Kas Elyas K; Friesland S; Ellingsen Cederoe T; Gerling M
Review: FRONTIERS IN ONCOLOGY. 2019;9:668
The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions
Guigay J; Tahara M; Licitra L; Keilholz U; Friesland S; Witzler P; Mesia R
Letter: ACTA ONCOLOGICA. 2018;57(4):557-560
The management and survival outcomes of nasopharyngeal cancer in the Nordic countries
Makitie A; Ruuskanen M; Bentzen J; Brun E; Gebre-Medhin M; Friesland S; Marsk E; Hammarstedt-Nordenvall L; Gille E; Reizenstein J; Adell G; Farnebo L; Rzepecki J; Haugen H; Soderstrom K; Zackrisson B; Bergstrom S; Loden B; Cederblad L; Laurell G; Smeland E; Evensen JF; Lund JA; Tondel H; Karlsdottir A; Johannsson J; Johansen J; Kristensen CA; Jensen K; Andersen LJ; Koivunen P; Korpela M; Voutilainen L; Wigren T; Minn H; Joensuu H; Overgaard J; Saarilahti KAlla författare
Review: ACTA ONCOLOGICA. 2017;56(10):1249-1257
Implementation of lung cancer CT screening in the Nordic countries
Pedersen JH; Sorensen JB; Saghir Z; Flotten O; Brustugun OT; Ashraf H; Strand T-E; Friesland S; Koyi H; Ek L; Nyren S; Bergman P; Jekunen A; Nieminen E-M; Gudbjartsson T
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2007;2(8):S448
How to improve loco-regional control in stage IIIa-b NSCLC?: Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group
Nyman J; Wagenius G; Friesland S; Seke M; Sederholm C; Loden B; Thaning L; Bergstrom S; Hallqvist A
Meeting abstract: RADIOTHERAPY AND ONCOLOGY. 2007;82:S1-S2
Preliminary results from a Swedish study of conventional versus accelerated fractionated of squamous carcinoma of the head and neck (artscan)
Zackrisson B; Kjellen E; Bjork-Eriksson J; Friesland S; Reizenstein J; Lagerlund M; Ekberg L; Loden B; Ahlgren J; Adell G; Bjornlinger K; Johansson KA
Meeting abstract: RADIOTHERAPY AND ONCOLOGY. 2006;78:S84
Significance of reference in tumour gene expression analyses by c-DNA array
Laytragoon-Lewin N; Lagerlund M; Ahlberg A; Castro J; Friesland S; Lundgren J; Nordiander B; Södergren T
Published conference paper: ACTA ONCOLOGICA. 2006;45(7):787-795
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Ericsson SR; Johansson K-A; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
Meeting abstract: VALUE IN HEALTH. 2004;7(6):681
Differences in treatment practice, response rates and cost of Epoetin alfa and Darbepoetin alfa treatment for anemic cancer patients: A retrospective analysis from Sweden
Persson U; Borg S; Jansson S; Ekman T; Franksson L; Friesland S; Larsson AM
Doctoral thesis: 2002
Factors of importance for radiosensitivity of tonsillar carcinoma
Friesland S

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI